Fast Drug Launch For Madrigal Pharmaceuticals Brings Buyout Discussion
Madrigal Pharmaceuticals' strong launch is confirmed with impressive sales in Q1 and Q2. Learn why MDGL stock could benefit ...
Malaysia Sun16h
Nasdaq Composite dips while broader markets close higher
Can you please write a news story about the closing stock market quotes for Wednesday for ALL the following indices but can ...
CureVac: Latest GBM Data Bodes Well For Next Program Check Point
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
Indaptus Therapeutics Provides Year-End Review and Outlook for 2025
Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
Solnerstotug (SNS-101) dose expansion arm anticipated to be fully enrolled by end of Q1 2025 - - Clinical data update expected in Q2 2025 - BOSTON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeu ...